Pil Sang Song, Seok-Woo Seong, Ji-Yeon Kim, Soo Yeon An, Mi Joo Kim, Kye Taek Ahn, Seon-Ah Jin, Jin-Ok Jeong, Jeong Hoon Yang, Joo-Yong Hahn, Hyeon-Cheol Gwon, Woo Jin Jang, Hyuck Jun Yoon, Jang-Whan Bae, Woong Gil Choi, Young Bin Song
{"title":"经皮冠状动脉介入治疗后服用 P2Y12 抑制剂单药 3 个月后，CHADS-P2A2RC 风险评分与临床结果的关系。","authors":"Pil Sang Song, Seok-Woo Seong, Ji-Yeon Kim, Soo Yeon An, Mi Joo Kim, Kye Taek Ahn, Seon-Ah Jin, Jin-Ok Jeong, Jeong Hoon Yang, Joo-Yong Hahn, Hyeon-Cheol Gwon, Woo Jin Jang, Hyuck Jun Yoon, Jang-Whan Bae, Woong Gil Choi, Young Bin Song","doi":"10.4070/kcj.2023.0268","DOIUrl":null,"url":null,"abstract":"Concerns remain that early aspirin cessation may be associated with potential harm in subsets at high risk of ischemic events. This study aimed to assess the effects of P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) vs. prolonged DAPT (12-month or longer) based on the ischemic risk stratification, the CHADS-P2A2RC, after percutaneous coronary intervention (PCI).","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"21 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention.\",\"authors\":\"Pil Sang Song, Seok-Woo Seong, Ji-Yeon Kim, Soo Yeon An, Mi Joo Kim, Kye Taek Ahn, Seon-Ah Jin, Jin-Ok Jeong, Jeong Hoon Yang, Joo-Yong Hahn, Hyeon-Cheol Gwon, Woo Jin Jang, Hyuck Jun Yoon, Jang-Whan Bae, Woong Gil Choi, Young Bin Song\",\"doi\":\"10.4070/kcj.2023.0268\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Concerns remain that early aspirin cessation may be associated with potential harm in subsets at high risk of ischemic events. This study aimed to assess the effects of P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) vs. prolonged DAPT (12-month or longer) based on the ischemic risk stratification, the CHADS-P2A2RC, after percutaneous coronary intervention (PCI).\",\"PeriodicalId\":17850,\"journal\":{\"name\":\"Korean Circulation Journal\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Korean Circulation Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4070/kcj.2023.0268\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Circulation Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4070/kcj.2023.0268","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention.
Concerns remain that early aspirin cessation may be associated with potential harm in subsets at high risk of ischemic events. This study aimed to assess the effects of P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) vs. prolonged DAPT (12-month or longer) based on the ischemic risk stratification, the CHADS-P2A2RC, after percutaneous coronary intervention (PCI).
期刊介绍：
Korean Circulation Journal is the official journal of the Korean Society of Cardiology, the Korean Pediatric Heart Society, the Korean Society of Interventional Cardiology, and the Korean Society of Heart Failure. Abbreviated title is ''Korean Circ J''.
Korean Circulation Journal, established in 1971, is a professional, peer-reviewed journal covering all aspects of cardiovascular medicine, including original articles of basic research and clinical findings, review articles, editorials, images in cardiovascular medicine, and letters to the editor. Korean Circulation Journal is published monthly in English and publishes scientific and state-of-the-art clinical articles aimed at improving human health in general and contributing to the treatment and prevention of cardiovascular diseases in particular.
The journal is published on the official website (https://e-kcj.org). It is indexed in PubMed, PubMed Central, Science Citation Index Expanded (SCIE, Web of Science), Scopus, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, KoreaMed, KoreaMed Synapse and KoMCI, and easily available to wide international researchers
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
